These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Relation of dementia, Alzheimer's disease and aging]. Koukolík F Cesk Patol; 1992 Mar; 28(1):14-20. PubMed ID: 1596940 [TBL] [Abstract][Full Text] [Related]
13. The choroid plexus transcriptome reveals changes in type I and II interferon responses in a mouse model of Alzheimer's disease. Mesquita SD; Ferreira AC; Gao F; Coppola G; Geschwind DH; Sousa JC; Correia-Neves M; Sousa N; Palha JA; Marques F Brain Behav Immun; 2015 Oct; 49():280-92. PubMed ID: 26092102 [TBL] [Abstract][Full Text] [Related]
14. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease. Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268 [TBL] [Abstract][Full Text] [Related]
16. Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases. Ray M; Ruan J; Zhang W Genome Biol; 2008 Oct; 9(10):R148. PubMed ID: 18842138 [TBL] [Abstract][Full Text] [Related]
17. Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered? Savory J; Exley C; Forbes WF; Huang Y; Joshi JG; Kruck T; McLachlan DR; Wakayama I J Toxicol Environ Health; 1996 Aug; 48(6):615-35. PubMed ID: 8772802 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589 [TBL] [Abstract][Full Text] [Related]
19. Integration of transcriptomic and genomic data suggests candidate mechanisms for APOE4-mediated pathogenic action in Alzheimer's disease. Caberlotto L; Marchetti L; Lauria M; Scotti M; Parolo S Sci Rep; 2016 Sep; 6():32583. PubMed ID: 27585646 [TBL] [Abstract][Full Text] [Related]
20. Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease. Matsuoka Y; Picciano M; La Francois J; Duff K Neuroscience; 2001; 104(3):609-13. PubMed ID: 11440793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]